IMMUNETHEP

📍 Cantanhede, Portugal🗓 Founded 2014👥 15 employees💰 Last funded Oct 2018
Biotechnology Research🌐 immunethep.com
Website LinkedIn
Immunethep is a biotech startup company (spin-off from the University of Porto) that is developing anti-bacterial immunotherapies based on the discovery of a virulence mechanism shared by different bacteria that cause life-threatening infections. We are working on preventing and treating infectious diseases to improve global health (SDG#3) for a safer tomorrow free of AntiMicrobial Resistance (AMR). We will accomplish our mission by developing anti-infective immunotherapies that potentiate a natural and strong immune response from the infected host, reducing the disease burden and mortality rates.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2014
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Portugal
1
Frequently asked questions
Who invested in IMMUNETHEP?
IMMUNETHEP has 1 investors on record on gritt.io, 1 mid-stage.
When did IMMUNETHEP last raise funding?
The most recent investment in IMMUNETHEP recorded on gritt.io was in October 2018.
When was IMMUNETHEP founded?
IMMUNETHEP was founded in 2014.
What industry is IMMUNETHEP in?
IMMUNETHEP operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is IMMUNETHEP based?
IMMUNETHEP is headquartered in Cantanhede, Portugal.